SynBioBeta Speaker
Colin Harvey
Co-founder & VP, Early Discovery
Hexagon Bio
May 2026, SynBioBeta
Speaker
Colin Harvey, PhD is Co-Founder and VP of Early Discovery at Hexagon Bio, where he leads efforts to harness microbial genomics and synthetic biology to discover novel therapeutics from nature. His work focuses on mining fungal genomes to uncover new bioactive compounds and translate them into drug candidates.Colin completed his PhD in Chemistry at Stanford University under Chaitan Khosla, where he developed approaches for engineering natural product biosynthesis, and subsequently conducted postdoctoral research with Ronald W. Davis at the Stanford Genome Technology Center where his work helped pioneer scalable platforms for heterologous expression and discovery of cryptic natural products.Since co-founding Hexagon Bio in 2017, Colin has built and led interdisciplinary teams integrating genomics, computation, and synthetic biology to systematically unlock new chemical space from the microbial world.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.